Amarin


How High Is the Blue Sky for Amarin (AMRN) Stock? This Analyst Boosts Price Target to $20

Can fish oil help prevent, or reduce the risk of heart disease? Ask Amarin (AMRN).

Amarin (AMRN) Stock: Next Stop, $15?

It’s a very rewarding trading day for investors in Amarin (AMRN) with shares up over 230%, making the stock Wall Street’s bull of …

Kala Pharmaceuticals (KALA), Durect (DRRX), and Amarin (AMRN) Reiterated with a Buy at H.C. Wainwright

In a research note issued Wednesday, H.C.

Analyst Backs Bullish View on Amarin Corporation (AMRN) Following Today’s Updates

Louise Chen at Cantor is out today with a fresh research note on shares of Amarin Corporation (NASDAQ:AMRN), after the drug maker posted two updates …

Amarin Corporation plc (ADR) (AMRN) Cashes Out; Shares Tumble

With its stock trading near a 52-week high, Amarin Corporation plc (ADR) (NASDAQ:AMRN) is cashing out at the top. On Monday, Amarin announced …

Company Update (NASDAQ:AMRN): Amarin Corporation plc Provides Preliminary 2017 Results and Provides 2018 Outlook

Amarin Corporation plc (NASDAQ:AMRN) provided a business update, including an update on 2017 revenue guidance, 2018 revenue forecast and potential 2018 milestones. Amarin …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces 3Q:17 Financial Results and Provides Update on Operations

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September 30, 2017, and provided an update on company …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and HLS Therapeutics Announce Agreement to Commercialize Vascepa in Canada

Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement between the parties to register, commercialize and distribute …

Amarin Corporation plc (ADR) (AMRN) Announces Two EPA-Related Data Presentations

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced two EPA-related data presentations unveiled this week at the American Diabetes Association® 77th Scientific Sessions in San …

H.C. Wainwright Maintains Neutral On Amarin Following 2Q14 Results

In a research note published August 8th, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts